Abstract:Nicotinamide adenine dinucleotide (NAD+) is an essential metabolite with wide-ranging and significant roles in the cell. Defects in NAD+ metabolism have been associated with many human disorders; it is therefore an emerging therapeutic target. Moreover, NAD+ metabolism is perturbed during colonization by a variety of pathogens, either due to the molecular mechanisms employed by these infectious agents or by the host immune response they trigger. Three main biosynthetic pathways, including the de novo and salvage pathways, contribute to the production of NAD+ with a high degree of conservation from bacteria to humans. De novo biosynthesis, which begins with l-tryptophan in eukaryotes, is also known as the kynurenine pathway. Intermediates of this pathway have various beneficial and deleterious effects on cellular health in different contexts. For example, dysregulation of this pathway is linked to neurotoxicity and oxidative stress. Activation of the de novo pathway is also implicated in various infections and inflammatory signaling. Given the dynamic flexibility and multiple roles of NAD+ intermediates, it is important to understand the interconnections and cross-regulations of NAD+ precursors and associated signaling pathways to understand how cells regulate NAD+ homeostasis in response to various growth conditions. Although regulation of NAD+ homeostasis remains incompletely understood, studies in the genetically tractable budding yeast Saccharomyces cerevisiae may help provide some molecular basis for how NAD+ homeostasis factors contribute to the maintenance and regulation of cellular function and how they are regulated by various nutritional and stress signals. Here we present a brief overview of recent insights and discoveries made with respect to the relationship between NAD+ metabolism and selected human disorders and infections, with a particular focus on the de novo pathway. We also discuss how studies in budding yeast may help elucidate the regulation of NAD+ homeostasis.

Regulation of and challenges in targeting NAD + metabolism

Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule

Nicotinamide Mononucleotide Supplementation: Understanding Metabolic Variability and Clinical Implications

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health

Implications of altered NAD metabolism in metabolic disorders

Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Novel approaches for better aging

From Bacteria to Biomedicine: Developing Therapies Exploiting NAD+ Metabolism.

NAD+ homeostasis in health and disease

The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions

Exploring NAD + metabolism and NNAT: Insights from structure, function, and computational modeling

NAD+ Metabolism, Metabolic Stress, and Infection

NAD+ metabolism and its roles in cellular processes during ageing

The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update

NAD+ metabolism, stemness, the immune response, and cancer

NAD metabolism: Role in senescence regulation and aging

Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Host–microbiome interactions in nicotinamide mononucleotide (NMN) deamidation

NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells

Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe?

NAD+ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications